Synlab remains in talks with Cinven five months after initial approach
Cinven listed lab diagnostics firm in April 2021 at EUR 18 per share and remains its largest shareholder
WestBridge raises GBP 130m in first close for third fund with debut deal in sight
UK-based PE firm has set GBP 200m hard-cap and target for the vehicle
Triton Partners exploring potential sale of Bormioli Pharma
Italian drug packaging company is likely to draw interest from strategics, plus sponsors with sector experience
Unicepta sponsor Paragon mandates Baird for potential exit
GP bought a majority stake in Germany-based media and marketing intelligence provider in 2018
EQT exits Schuelke to Athos-led consortium
The Munich-based family office has been an LP in EQT's funds; joined recent co-investment tickets
GP Profile: Baird Capital puts lower-middle-market niche and global expansion offering to work
GPтs flexible deal structure proposition resonates particularly well with founders in the current environment, Michael Holgate told Unquote
Groupe Vilavi stays French and starts new chapter with HLD
Insurance company is valued at around EUR 300m and will focus on organic and external growth with new majority owner
Bregal eyes local deal origination with new Swiss office
GP's third fund is completing its investment period, with fourth fund registered
Moneycorp sponsor Bridgepoint finalises sale prep for exit
GP has held the UK-based foreign exchange specialist since 2014, when it acquired it for GBP 212m
IPACKCHEM sale attracts Greif, other packaging strategics and sponsors
SK Capital is orking with sellside adviser Goldman Sachs on the process for the French packaging firm
Blatchford backer CBPE mandates Investec to oversee imminent exit
GP began weighing options for UK-based prosthetics manufacturer last July
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Golding eyes 2024 final close for latest secondaries fund, targets 'undercapitalised' small- and mid-cap space
Asset manager is targeting EUR 500m and is seeing discounts on both GP-led and LP stakes deals
Wise Equity exits Cantiere del Pardo in trade sale
Sale of yachts manufacturer to Calzedonia Group marks second exit from GP’s fifth fund
Princes Group sale restart scheduled for September
Mitsubishi Corporation-owned food and drink manufacturer saw significant PE interest in first round
Bain Capital intensifies strategy specialisation efforts with USD 1.15bn insurance fund
New fund will deploy tickets of up to USD 200m but is 'not afraid to start small', Matt Popoli said
Warburg Pincus poaches former Evercore MD to co-head Europe
Andrew Sibbald succeeds Adarsh Sarmam, who will remain a managing director and partner
Inflexion to exit Xtrac in SBO to MiddleGround Capital
Sale of UK-based transmission-systems manufacturer marks Buyout Fund IVтs seventh exit
Teasers out for Ardian-backed imes-icore
No formal process has kicked off for the German medtech firm but significant sponsor interest is expected
Unquote British Private Equity Awards 2023: one week left to enter
Submit your entry for the 2023 Unquote British Private Equity Awards before 7th August 2023 at 4pm
Blackstone takes minority stake in Groupe Premium
Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn
Apax acquires co-controlling stake in Fremman Capital-backed Palex Medical
Deal values Spain-headquartered medical equipment distributor at around EUR 1bn
AnaCap in advanced talks for two deals; has 'exciting' financial services and tech pipeline
Financial services-focused sponsor is honing in on one majority and one minority stake deal
Capvis partner to join Bregal as head of Switzerland
Simon Lussi joined Swiss GP Capvis in 2015 and had been a partner since April 2021